Artivion Initiates Enrollment in PERSEVERE Clinical Trial
Artivion advises the trial is designed to support the company's forthcoming application to the U.S. Food and Drug Administration for premarket approval of the AMDS.
Artivion advises the trial is designed to support the company's forthcoming application to the U.S. Food and Drug Administration for premarket approval of the AMDS.
Copyright 2025 | All Rights Reserved | Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.